DGX - Quest Diagnostics Incorporated

NYSE - NYSE Delayed Price. Currency in USD
99.28
-1.59 (-1.58%)
At close: 4:01PM EDT

99.28 0.00 (0.00%)
After hours: 5:19PM EDT

Stock chart is not supported by your current browser
Previous Close100.87
Open100.77
Bid99.54 x 800
Ask99.56 x 1000
Day's Range99.21 - 100.98
52 Week Range78.95 - 115.64
Volume951,602
Avg. Volume984,558
Market Cap13.341B
Beta (3Y Monthly)0.89
PE Ratio (TTM)19.01
EPS (TTM)5.22
Earnings DateJul 23, 2019
Forward Dividend & Yield2.12 (2.10%)
Ex-Dividend Date2019-07-05
1y Target Est101.11
Trade prices are not sourced from all markets
  • Business Wire24 minutes ago

    QUEST DIAGNOSTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Quest Diagnostics Incorporated - DGX

    Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC , announces that KSF has commenced an investigation into Quest Diagnostics Incorporated .

  • Will 2-Pronged Plan Aid Quest Diagnostics (DGX) Q2 Earnings?
    Zacks2 days ago

    Will 2-Pronged Plan Aid Quest Diagnostics (DGX) Q2 Earnings?

    Quest Diagnostics' (DGX) frequent partnership wins with health care leaders and sensible buyouts are creating bountiful opportunities for the top and the bottom line.

  • Quest Diagnostics Welcomes New Members to the Global Diagnostics Network (GDN)
    PR Newswire2 days ago

    Quest Diagnostics Welcomes New Members to the Global Diagnostics Network (GDN)

    SECAUCUS, N.J., July 18, 2019 /PRNewswire/ -- Quest Diagnostics (DGX), the world's leading provider of diagnostic information services, announced today the expansion of the Global Diagnostics Network (GDN), a strategic working group of major diagnostic laboratories collaborating to generate enhanced diagnostics insights to improve the delivery of global healthcare. Regional companies LSI Medience, and Strand Life Sciences join Quest and the charter members -- Al Borg Medical Laboratories, Dasa, GC Labs, Healius, KingMed Diagnostics, SYNLAB – as GDN members.

  • Another 2.2 million patients affected by AMCA data breach
    TechCrunch3 days ago

    Another 2.2 million patients affected by AMCA data breach

    Another clinical lab ensnared in the AMCA data breach has come forward. Clinical Pathology Laboratories (CPL) says 2.2 million patients may have had their names, addresses, phone numbers, dates of birth, dates of service, balance information and treatment provider information stolen in the previously reported breach. Another 34,500 patients had their credit card or banking information compromised.

  • PR Newswire3 days ago

    Quest Diagnostics Named one of the "Best Places to Work for Disability Inclusion"

    SECAUCUS, N.J. , July 17, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has been named to the 2019 Disability Equality ...

  • Catholic Health Services Partners with Quest Diagnostics to Deliver High-Value, Innovative Laboratory Services
    PR Newswire3 days ago

    Catholic Health Services Partners with Quest Diagnostics to Deliver High-Value, Innovative Laboratory Services

    SECAUCUS, N.J. and ROCKVILLE CENTRE, N.Y., July 17, 2019 /PRNewswire/ -- Catholic Health Services (CHS), an integrated health care delivery system with a 24% market share on Long Island, is teaming up with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, to enhance the quality and value of diagnostic services to patients and their doctors. "We are pleased to partner with Catholic Health Services, a leader in health care delivery on Long Island," said Quest Diagnostics Chairman, President and CEO Steve Rusckowski.

  • Earnings Preview: Quest Diagnostics (DGX) Q2 Earnings Expected to Decline
    Zacks4 days ago

    Earnings Preview: Quest Diagnostics (DGX) Q2 Earnings Expected to Decline

    Quest Diagnostics (DGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • PR Newswire8 days ago

    Sharecare names Quest Diagnostics its preferred laboratory partner to advance digital health management

    ATLANTA, July 12, 2019 /PRNewswire/ -- Sharecare, the digital health company that helps people manage all their health in one place, and Quest Diagnostics (DGX) have formed a collaboration designed to improve digital health and disease management for a range of health care consumers. Sharecare has named Quest its preferred laboratory partner for its comprehensive digital health platform. Sharecare and Quest Diagnostics also intend to jointly explore the development of disease management programs and other services to empower better health.

  • Quest Diagnostics To Release Second Quarter 2019 Financial Results On July 23
    PR Newswire11 days ago

    Quest Diagnostics To Release Second Quarter 2019 Financial Results On July 23

    Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management.

  • Markit11 days ago

    See what the IHS Markit Score report has to say about Quest Diagnostics Inc.

    Quest Diagnostics Inc NYSE:DGXView full report here! Summary * Perception of the company's creditworthiness is positive * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for DGX with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $3.37 billion over the last one-month into ETFs that hold DGX are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swap | PositiveThe current level displays a positive indicator. DGX credit default swap spreads are within the middle of their range for the last three years.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Women Health a Top Priority Now: 3 Stocks to Watch
    Zacks11 days ago

    Women Health a Top Priority Now: 3 Stocks to Watch

    Women's healthcare gains global importance, investors might want to keep an eye on these stocks.

  • QUEST DIAGNOSTICS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Quest Diagnostics Incorporated - DGX
    PR Newswire28 days ago

    QUEST DIAGNOSTICS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Quest Diagnostics Incorporated - DGX

    NEW ORLEANS , June 21, 2019 /PRNewswire/ -- Former Attorney General of Louisiana , Charles C. Foti, Jr., Esq. , a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF ...

  • DGX vs. CHE: Which Stock Is the Better Value Option?
    Zackslast month

    DGX vs. CHE: Which Stock Is the Better Value Option?

    DGX vs. CHE: Which Stock Is the Better Value Option?

  • Is Quest Diagnostics Incorporated (NYSE:DGX) A Smart Pick For Income Investors?
    Simply Wall St.last month

    Is Quest Diagnostics Incorporated (NYSE:DGX) A Smart Pick For Income Investors?

    Today we'll take a closer look at Quest Diagnostics Incorporated (NYSE:DGX) from a dividend investor's perspective...

  • GuruFocus.comlast month

    Quest Diagnostics Inc (DGX) Chairman, President and CEO Stephen H Rusckowski Sold $24. ...

    Chairman, President and CEO of Quest Diagnostics Inc (NYSE:DGX) Stephen H Rusckowski sold 244,565 shares of DGX on 06/13/2019 at an average price of $100 a share.

  • Employer Wellness Screening with Digital Diabetes Prevention Program May Lower Eight-Year Risk of Diabetes, Suggests Quest Diagnostics Study
    PR Newswirelast month

    Employer Wellness Screening with Digital Diabetes Prevention Program May Lower Eight-Year Risk of Diabetes, Suggests Quest Diagnostics Study

    SECAUCUS, N.J., June 17, 2019 /PRNewswire/ -- Individuals with prediabetes who participate in an employer-sponsored digital diabetes-prevention counseling program may reduce their risk of developing type 2 diabetes (T2D) for up to eight years, according to a new study from Quest Diagnostics (DGX), the world's leading provider of diagnostic information services. The new study, "Digital Behavioral Counseling in a Workforce Setting Reduces 8-Year Risk of Developing Type 2 Diabetes" (77-LB), is believed to be the first to suggest lower risk of diabetes may be sustained following participation in a time-limited digital Diabetes Prevention Program (DPP).

  • GlobeNewswirelast month

    Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Quest Diagnostics Incorporated (NYSE: DGX) and Encourages Quest Diagnostics Investors to Contact the Firm

    NEW YORK, June 09, 2019 -- Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Quest Diagnostics Incorporated (NYSE:.

  • PR Newswirelast month

    Faruqi & Faruqi, LLP is Investigating Quest Diagnostics Incorporated (DGX) on Behalf of its Shareholders

    NEW YORK , June 6, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential misconduct at Quest Diagnostics Incorporated ("Quest Diagnostics" ...

  • Reuterslast month

    UPDATE 1-Opko Health says over 400,000 customers likely affected by data breach

    Opko Health Inc said on Thursday it was notified by its former billing collections vendor about unauthorized access to information on about 422,600 customers, making it the third healthcare company to be affected by the incident. American Medical Collection Agency (AMCA) informed Opko Health that the compromised data may include credit card and bank account information, email addresses and other data such as address, phone number and balance information. Earlier this week, rivals Quest Diagnostics Inc and Laboratory Corporation of America Holdings also announced that they were apprised of unauthorized access to their customer data stored on AMCA system.

  • Here's Why You Should Invest in Quest Diagnostics (DGX) Stock
    Zackslast month

    Here's Why You Should Invest in Quest Diagnostics (DGX) Stock

    Quest Diagnostics (DGX) is boosting investors' optimism, courtesy of consistent positive results.

  • Senator warns of 'irreparable' consumer harm after data breach
    Yahoo Financelast month

    Senator warns of 'irreparable' consumer harm after data breach

    Senators demand answers from Quest Diagnostics and LabCorp after a data breach may have put millions of consumers' information at risk.